Bone marrow-derived mesenchymal stem cells protect against experimental liver fibrosis in rats
Open accessThe DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
AIM: Recent reports have shown the capacity of mesenchymal stem cells (MSCs) to differentiate into hepatocytes in vitro and in vivo. MSCs administration could repair injured liver, lung, or heart through reducing inflammation, collagen deposition, and remodeling. These results provide a clue to treatment of liver fibrosis. The aim of this study was to investigate the effect of infusion of bone marrow (BM)-derived MSCs on the experimental liver fibrosis in rats. METHODS: MSCs isolated from BM in male Fischer 344 rats were infused to female Wistar rats induced with carbon tetrachloride (CCl4) or dimethylnitrosamine (DMN). There were two random groups on the 42nd d of CCl4:CCl4/MSCs, to infuse a dose of MSCs alone; CCl4/saline, to infuse the same volume of saline as control. There were another three random groups after exposure to DMN: DMN10/MSCs, to infuse the same dose of MSCs on d 10; DMN10/saline, to infuse the same volume of saline on d 10; DMN20/MSCs, to infuse the same dose of MSCs on d 20. The morphological and behavioral changes of rats were monitored everyday. After 4-6 wk of MSCs administration, all rats were killed and fibrosis index were assessed by histopathology and radioimmunoassay. Smooth muscle alpha-actin (alpha-SMA) of liver were tested by immunohistochemistry and quantified by IBAS 2.5 software. Male rats sex determination region on the Y chromosome (sry) gene were explored by PCR. RESULTS: Compared to controls, infusion of MSCs reduced the mortality rates of incidence in CCl4-induced model (10% vs 20%) and in DMN-induced model (20-40% vs 90%). The amount of collagen deposition and alpha-SMA staining was about 40-50% lower in liver of rats with MSCs than that of rats without MSCs. The similar results were observed in fibrosis index. And the effect of the inhibition of fibrogenesis was greater in DMN10/MSCs than in DMN20/MSCs. The sry gene was positive in the liver of rats with MSCs treatment by PCR. CONCLUSION: MSCs treatment can protect against experimental liver fibrosis in CCl4-induced or DMN-induced rats and the mechanisms of the anti-fibrosis by MSCs will be studied further.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED ARTICLE: Pluripotency of mesenchymal stem cells derived from adult marrow
Jiang, Y., Jahagirdar, B. N., Reinhardt, R. L., Schwartz, R. E., Keene, C. D., Ortiz-Gonzalez, X. R., Reyes, M., Lenvik, T., Lund, T., Blackstad, M., et al. (2002) · Nature · doi:10.1038/nature00870 · Cited by 5,518
RetractedHuman Mesenchymal Stem Cells Differentiate to a Cardiomyocyte Phenotype in the Adult Murine Heart
Toma, C., Pittenger, M. F., Cahill, K. S., Byrne, B. J., & Kessler, P. D. (2002) · Circulation · doi:10.1161/hc0102.101442 · Cited by 2,234
Liver fibrosis – from bench to bedside
Friedman, S. L. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00429-4 · Cited by 1,780
Mangi, A. A., Noiseux, N., Kong, D., He, H., Rezvani, M., Ingwall, J. S., & Dzau, V. J. (2003) · Nature Medicine · doi:10.1038/nm912 · Cited by 1,509
Tse, W. T., Pendleton, J. D., Beyer, W. M., Egalka, M. C., & Guinan, E. C. (2003) · Transplantation · doi:10.1097/01.tp.0000045055.63901.a9 · Cited by 1,500
Ortiz, L. A., Gambelli, F., McBride, C., Gaupp, D., Baddoo, M., Kaminski, N., & Phinney, D. G. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1432929100 · Cited by 1,445
Kinnaird, T., Stabile, E., Burnett, M. S., Shou, M., Lee, C. W., Barr, S., Fuchs, S., & Epstein, S. E. (2004) · Circulation · doi:10.1161/01.cir.0000124062.31102.57 · Cited by 1,305
Iredale, J. P., Benyon, R. C., Pickering, J., McCullen, M., Northrop, M., Pawley, S., Hovell, C., & Arthur, M. J. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1018 · Cited by 1,075 · cited 1×
“Although this model could undergo spontaneous resolution of fibrosis after stopping CCl4 challenging in some reports[ 22 ], we here did not find recovery of liver fibrosis in CCl4/saline within 4 wk of withdrawal of CCl4.”
MethodHuman marrow stromal cell therapy for stroke in rat: Neurotrophins and functional recovery
Li, Y., Chen, J., Chen, X. G., Wang, L., Gautam, S. C., Xu, Y. X., Katakowski, M., Zhang, L. J., Lu, M., Janakiraman, N., et al. (2002) · Neurology · doi:10.1212/wnl.59.4.514 · Cited by 869
In vitro Hepatic Differentiation of Human Mesenchymal Stem Cells
Lee, K., Kuo, T. K., Whang–Peng, J., Chung, Y., Lin, C., Chou, S., Chen, J., Chen, Y., & Lee, O. K. (2004) · Hepatology · doi:10.1002/hep.20469 · Cited by 865 · cited 1×
“capacity of MSCs to differentiate into hepatocytes in vitro[10, 11 ,] and in vivo[6,12,13].”
BackgroundSchwartz, R. E., Reyes, M., Koodie, L., Jiang, Y., Blackstad, M., Lund, T., Lenvik, T., Johnson, S., Hu, W.-S., & Verfaillie, C. M. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215182 · Cited by 863
Silva, G. V., Litovsky, S., Assad, J. A. R., Sousa, A. L. S., Martin, B. J., Vela, D., Coulter, S. C., Lin, J., Ober, J., Vaughn, W. K., et al. (2005) · Circulation · doi:10.1161/01.cir.0000151812.86142.45 · Cited by 801
Devine, S. M., Cobbs, C., Jennings, M., Bartholomew, A., & Hoffman, R. (2003) · Blood · doi:10.1182/blood-2002-06-1830 · Cited by 740
Hepatocyte growth factor gene therapy of liver cirrhosis in rats
Ueki, T., Kaneda, Y., Tsutsui, H., Nakanishi, K., Sawa, Y., Morishita, R., Matsumoto, K., Nakamura, T., Takahashi, H., Okamoto, E., et al. (1999) · Nature Medicine · doi:10.1038/5593 · Cited by 587
Mesenchymal stem cells: paradoxes of passaging
Javazon, E. H., Beggs, K. J., & Flake, A. W. (2004) · Experimental Hematology · doi:10.1016/j.exphem.2004.02.004 · Cited by 527
Transplantation of Bone Marrow Cells Reduces Ccl4–Induced Liver Fibrosis in Mice
Sakaida, I., Terai, S., Yamamoto, N., Aoyama, K., Ishikawa, T., Nishina, H., & Okita, K. (2004) · Hepatology · doi:10.1002/hep.20452 · Cited by 524
Fang, B., Shi, M., Liao, L., Yang, S., Liu, Y., & Zhao, R. C. (2004) · Transplantation · doi:10.1097/01.tp.0000128326.95294.14 · Cited by 271
Nakamura, T., Sakata, R., Ueno, T., Sata, M., & Ueno, H. (2000) · Hepatology · doi:10.1053/jhep.2000.9109 · Cited by 242
Dimethylnitrosamine-induced liver injury in rats: the early deposition of collagen
George, J., Rao, K. R., Stern, R., & Chandrakasan, G. (2001) · Toxicology · doi:10.1016/s0300-483x(00)00352-8 · Cited by 198
Parsons, C. J., Bradford, B. U., Pan, C. Q., Cheung, E., Schauer, M., Knorr, A., Krebs, B., Kraft, S., Zahn, S., Brocks, B., et al. (2004) · Hepatology · doi:10.1002/hep.20425 · Cited by 193
Cirrhosis: new research provides a basis for rational and targeted treatments
Iredale, J. P. (2003) · BMJ · doi:10.1136/bmj.327.7407.143 · Cited by 192
Trim, N., Morgan, S., Evans, M., Issa, R., Fine, D., Afford, S., Wilkins, B., & Iredale, J. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64994-2 · Cited by 187
Little evidence of bone marrow-derived hepatocytes in the replacement of injured liver
Kanazawa, Y., & Verma, I. M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1834198100 · Cited by 144
Use of a Rat cDNA Probe Specific for the Y Chromosome to Detect Male‐Derived Cells
AN, J., Beauchemin, N., Albanese, J. M., Abney, T. O., & Sullivan, A. K. (1997) · Journal of Andrology · doi:10.1002/j.1939-4640.1997.tb01921.x · Cited by 62
Matsuda-Hashii, Y., Takai, K., Ohta, H., Fujisaki, H., Tokimasa, S., Osugi, Y., Ozono, K., Matsumoto, K., Nakamura, T., & Hara, J. (2004) · Experimental Hematology · doi:10.1016/j.exphem.2004.06.012 · Cited by 62
Factors affecting graft survival after living donor liver transplantation
Lee, D. S., Gil, W. H., Lee, H. H., Lee, K. W., Lee, S. K., Kim, S. J., Choi, S. H., Heo, J. S., Hyon, W. S., Kim, G. S., et al. (2004) · Transplantation Proceedings · doi:10.1016/j.transproceed.2004.08.073 · Cited by 58
Wu, G. D., Tuan, T., Bowdish, M. E., et al. (2003) · Transplantation · doi:10.1097/01.tp.0000066362.37931.6d · Cited by 27
Cited by
Paracrine Mechanisms of Mesenchymal Stem Cells in Tissue Repair
Gnecchi, M., Danieli, P., Malpasso, G., & Ciuffreda, M. C. (2016) · Methods in Molecular Biology · doi:10.1007/978-1-4939-3584-0_7 · Cited by 449
Immune modulation by mesenchymal stem cells
Rasmusson, I. (2006) · Experimental Cell Research · doi:10.1016/j.yexcr.2006.03.019 · Cited by 374
Banas, A., Teratani, T., Yamamoto, Y., Tokuhara, M., Takeshita, F., Osaki, M., Kawamata, M., Kato, T., Okochi, H., & Ochiya, T. (2008) · Stem Cells · doi:10.1634/stemcells.2008-0034 · Cited by 306
Therapeutic potential of bone marrow-derived mesenchymal stem cells on experimental liver fibrosis
Abdel Aziz, M. T., Atta, H. M., Mahfouz, S., Fouad, H. H., Roshdy, N. K., Ahmed, H. H., Rashed, L. A., Sabry, D., Hassouna, A. A., & Hasan, N. M. (2007) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2007.04.017 · Cited by 292
Ma, P.-F., Gao, C.-C., Yi, J., Zhao, J.-L., Liang, S.-Q., Zhao, Y., Ye, Y.-C., Bai, J., Zheng, Q.-J., Dou, K.-F., et al. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.05.022 · Cited by 284
Metadata
- Authors
- Zhao, D.-C.
- Venue
- World Journal of Gastroenterology
- Publisher
- Baishideng Publishing Group Inc.
- Published
- 2005
- Volume
- 11
- Issue
- 22
- Pages
- 3431
- ISSN
- 1007-9327 (ISSN-L)
- OpenAlex
- W2115335074
- Cited by
- 277
- References
- 27
- FWCI
- 6.40
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.